Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Current Allergy and Asthma Reports
|
October 2, 2014
Modified allergens and their potential to treat allergic disease
Laurian Jongejan, Ronald van Ree
Expert Review of Clinical Immunology
|
November 13, 2015
Hypoallergenic molecules for subcutaneous immunotherapy
Laurian Jongejan, Ronald van Ree, Lars K Poulsen
Frontiers in Immunology
|
October 5, 2020
<i>In vivo</i> Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 Variant
Lorenz Aglas, Athanasios Bethanis, Paulina Chrusciel, et al.
Allergy
|
June 2, 2025
Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG<sub>1</sub> Instead of IgG<sub>4</sub>
Lorenz Aglas, Line Kring Tannert, Serge A Versteeg, et al.
Molecular Nutrition & Food Research
|
June 18, 2019
Rational Design, Structure-Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants
Stephanie Eichhorn, Angelika Hörschläger, Markus Steiner, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2024
Persistence, Severity, and Reactivity Thresholds in Fish-Allergic Patients Sensitized to Parvalbumin
Rosialzira Natasha Vera-Berrios, Sonia Vázquez-Cortés, Alejandro Gonzalo-Fernández, et al.
Frontiers in Allergy
|
April 7, 2022
Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles
Mareen R Datema, Sarah A Lyons, Montserrat Fernández-Rivas, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 11, 2020
Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity
Sarah A Lyons, Mareen R Datema, Thuy-My Le, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Current Allergy and Asthma Reports
|
October 2, 2014
Modified allergens and their potential to treat allergic disease
Laurian Jongejan, Ronald van Ree
Expert Review of Clinical Immunology
|
November 13, 2015
Hypoallergenic molecules for subcutaneous immunotherapy
Laurian Jongejan, Ronald van Ree, Lars K Poulsen
Frontiers in Immunology
|
October 5, 2020
<i>In vivo</i> Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 Variant
Lorenz Aglas, Athanasios Bethanis, Paulina Chrusciel, et al.
Allergy
|
June 2, 2025
Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG<sub>1</sub> Instead of IgG<sub>4</sub>
Lorenz Aglas, Line Kring Tannert, Serge A Versteeg, et al.
Molecular Nutrition & Food Research
|
June 18, 2019
Rational Design, Structure-Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants
Stephanie Eichhorn, Angelika Hörschläger, Markus Steiner, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2024
Persistence, Severity, and Reactivity Thresholds in Fish-Allergic Patients Sensitized to Parvalbumin
Rosialzira Natasha Vera-Berrios, Sonia Vázquez-Cortés, Alejandro Gonzalo-Fernández, et al.
Frontiers in Allergy
|
April 7, 2022
Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles
Mareen R Datema, Sarah A Lyons, Montserrat Fernández-Rivas, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
September 11, 2020
Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity
Sarah A Lyons, Mareen R Datema, Thuy-My Le, et al.
Page
of 1